Surgical resection for hepatocellular carcinoma

PEI versus PAI did not differ significantly regarding benefits and harms in people with early HCC, but the two included trials had only a limited number of participants and one trial was judged a high risk of bias. Thus, the current evidence precludes us from making any firm conclusions.There was also insufficient evidence to determine whether PEI versus surgery (segmental liver resection) was more effective, because conclusions were based on a single randomised trial. While some data from this single trial suggested that PEI was safer, the high risk of bias and the lack of any confirmatory evidence make a reliable assessment impossible.We found no trials assessing PEI or PAI versus no intervention, best supportive care, or sham intervention.There is a need for more randomised clinical trials assessing interventions for people with early stage HCC. Such trials should be conducted with low risks of systematic errors and random errors.

show abstract

Anterior approach versus conventional liver resection for hepatocellular carcinoma

Wang

Zheng

et al. 2013

Cochrane Database of Systematic Reviews

View full text Add to dashboard Cite

Surgical resection for hepatocellular carcinoma

Cited by 4 publications

References 53 publications

Percutanous ethanol injection or percutaneous acetic acid injection for early hepatocellular carcinoma

Percutanous ethanol injection or percutaneous acetic acid injection for early hepatocellular carcinoma

Percutaneous ethanol injection or percutaneous acetic acid injection for early hepatocellular carcinoma

Anterior approach versus conventional liver resection for hepatocellular carcinoma

Contact Info

Product

Resources

About